Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-004972

President sold 15,000 shares at an average $66.56 ($998,445)

  • President acquired 15,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

RUBINSTEIN JULIE · President

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2021-01-21 Exercise or conversion : show line 1 in the form +15,000 $6.32 $94,800 15,000 D
2021-01-21 Sale : show line 2 in the form −6,444 $66.15 $426,271 8,556 D
2021-01-21 Sale : show line 3 in the form −8,511 $66.87 $569,131 45 D
2021-01-21 Sale : show line 4 in the form −45 $67.63 $3,043 0 D
Open-market sales · 15,000 sh · avg $66.56 · $998,445

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-01-21 Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) −15,000 185,000 D
Loading xslF345X03/doc4.xml…